Advertisement

November 24, 2012

Drug Company Money Undermines Science

Charles Seife, Scientific American


AP Photo

When Robert Lindsay chose to become a medical researcher in the early 1970s, he did not do it for the money. His field—the effect of hormones on bone—was a backwater. It was also a perfect opportunity for a young researcher to make his mark and, he hoped, help millions of people who suffered from the bone disease osteoporosis.

Read Full Article ››

TAGGED: National Institute of Health, scientific research, money, pharmaceutical manufacturers

RECOMMENDED ARTICLES

November 17, 2012
Survival of the Sexiest
Matt Ridley, Wall Street Journal
Evolution by sexual selection is an idea that goes back to Charles Darwin. He had little doubt that it explained much about human beings, and modern biologists generally agree. One of them has even put a figure on it,... more ››
November 14, 2012
Trying to Save Money? Ask for Crisp New Bills
EurekAlert!
Consumers will spend more to get rid of worn bills because they evoke feelings of disgust but are more likely to hold on to crisp new currency, according to a new study in the Journal of Consumer Research. more ››
November 24, 2012
Why Scientific Research Is a Ponzi Scheme
Steve Caplan, The Guardian
Ponzi schemes are typically scams that involve the recruitment of investors, who initially receive high returns for their investments and recruit other investors – until this pyramid collapses, and those at the bottom end... more ››
November 21, 2012
Science Publication Becoming 50 Shades of Grey
Douglas Fields, HuffPo
Newsweek is dead. But we have Twitter. Harper-Collins just closed its last warehouse of books in the United States. Cambridge University Press, the oldest publisher of scholarly books and journals in the world, printing... more ››
|